http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102702052-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48df6bc4ebf937c660e36d97dec66663
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-13
filingDate 2012-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6313686934a5f806b27588964a6a80a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10dc95c979d6f93723e380b0db81e6f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cce3a4194debd0faa657a8002b0042ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ee6f7d71cdadb49a40f98c6533f253d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f77f7a7c4b9a2aab27f7135831e9cf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc847ce0a2da38adec8182ba61e54ac8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a591b2a4ac05774750544693256010
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12fd171fc869d6a10bbf741d32881efd
publicationDate 2012-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102702052-A
titleOfInvention Novel farnesylthiosalicylic acid derivative containing diamines, its preparation method and its medical application
abstract The present invention provides a class of novel farnesylthiosalicylic acid derivatives containing diamines and pharmaceutically acceptable salts thereof, their preparation methods, pharmaceutical compositions containing these derivatives and their medical applications , especially in the preparation of antitumor drugs and neuroprotective drugs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106619660-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110691838-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104292139-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111925362-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450062-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450062-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111925362-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103864720-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450301-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103864720-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450301-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104829671-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104292139-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103113274-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104292140-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104829671-A
priorityDate 2012-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007037887-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010189781-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005119237-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467613779

Total number of triples: 49.